Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

202292 citationsJournal Articlehybrid Open Access

Authors

Patients treated with OCA in a trial setting had significantly greater transplant-free survival than comparable external control patients.

Good health and well-being

Published in: Gastroenterology

Volume 163, Issue 6, pp. 1630-1642.e3

Field-Weighted Citation Impact: 12.33